Mateos M, Rodríguez-Otero P, Usmani S, Kumar S, Ye J, Atrash S, Magen H, Quach H, Chu M, Trudel S, Richter J, Chuah H, Gatt M, Medvedova E, Raza S, Yoon D, Ishida T, Matous J, Rosiñol L, Onodera K, Maffucci C, Scott E, Heuck C, Zhang J, Henninger T, O’Rourke L, Thakkar P, Festa M, Huang L, Zhou J, Takamoto M, Pei L, Lu J, Au N, Krevvata M, Cohen Y. P40 | EFFICACY AND SAFETY OF TALQUETAMAB + TECLISTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND EXTRAMEDULLARY DISEASE: UPDATED PHASE 2 RESULTS FROM THE RedirecTT-1 STUDY WITH EXTENDED FOLLOW-UP. Haematologica 2026; 111(s2); https://doi.org/10.3324/haematol.2026.s2.14055.